Insider holders · CIK 0001621443
Zynerba Pharmaceuticals, Inc. · ZYNE
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Michael Rapp10% Owner | 1,500,000 | 80,467 | 1,580,467 | May 31, 2018 · 9:26 am EDT | Form 4 |
| Armando AnidoChairman & Chief Exec. Officer | 352,512 | 13,297 | 365,809 | Aug 7, 2018 · 4:32 pm EDT | Form 4 |
| Terri B SebreePresident | 186,146 | — | 186,146 | Jan 28, 2019 · 4:20 pm EST | Form 4 |
| Suzanne M. HanlonSec, VP & General Counsel | 43,693 | 0 | 43,693 | Aug 7, 2018 · 4:30 pm EDT | Form 4 |
| James E FickenscherChief Financial Officer | 20,718 | — | 20,718 | Aug 7, 2018 · 4:28 pm EDT | Form 4 |
| Richard A BaronChief Financial Officer | 15,957 | — | 15,957 | Sep 15, 2015 · 1:48 pm EDT | Form 4 |
| Thomas L HarrisonDirector | 12,500 | — | 12,500 | Aug 12, 2015 · 11:48 am EDT | Form 4 |
| John P. ButlerDirector | 5,000 | — | 5,000 | Aug 22, 2018 · 4:39 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.